TANCOGNE Xavier – Trademark Portfolio

Entity Type: 01

TANCOGNE Xavier holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 5 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include LABO. DERMA and FAIR & WHITE HEALTH SECURITY LABO DERMA PARIS.

5, avenue du Bassin

F-33115 PYLA SUR MER

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

TANCOGNE Xavier's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (5 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does TANCOGNE Xavier have?

TANCOGNE Xavier has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 abandoned, 1 cancelled.

What trademark classes does TANCOGNE Xavier file in?

TANCOGNE Xavier files trademarks across 2 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are TANCOGNE Xavier's most well-known trademarks?

TANCOGNE Xavier's registered trademark portfolio includes well-known marks such as LABO. DERMA and FAIR & WHITE HEALTH SECURITY LABO DERMA PARIS. These are among 2 currently registered trademarks in the portfolio.

What is TANCOGNE Xavier's trademark registration success rate?

TANCOGNE Xavier has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.